PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Biol Chem. Author manuscript; available in PMC Feb 22, 2009.
Published in final edited form as:
PMCID: PMC2408380
NIHMSID: NIHMS49723
Subunit H of the V-ATPase Inhibits ATP Hydrolysis by the Free V1 Domain by Interaction with the Rotary Subunit F
Kevin C. Jefferies and Michael Forgac
From the Department of Physiology, Tufts University School of Medicine, Boston, MA 02111
¶ To whom correspondence should be addressed: Department of Physiology, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111. Tel: 617-636-6939; Fax: 617-636-0445; e-mail: michael.forgac/at/tufts.edu
The vacuolar (H+)-ATPases (V-ATPases) are large, multimeric proton pumps that, like the related family of F1F0 ATP synthases, employ a rotary mechanism. ATP hydrolysis by the peripheral V1 domain drives rotation of a rotary complex (the rotor) relative to the stationary part of the enzyme (the stator), leading to proton translocation through the integral V0 domain. One mechanism of regulating V-ATPase activity in vivo involves reversible dissociation of the V1 and V0 domains. Unlike the corresponding domains in F1F0, the dissociated V1 domain does not hydrolyze ATP and the free V0 domain does not passively conduct protons. These properties are important to avoid generation of an uncoupled ATPase activity or an unregulated proton conductance upon dissociation of the complex in vivo. Previous results (Parra, K.J., Keenan K.L., and Kane P.M., (2000) J. Biol. Chem. 275, 21761–7) showed that subunit H (part of the stator) inhibits ATP hydrolysis by free V1. To test the hypothesis that subunit H accomplishes this by bridging rotor and stator in free V1, cysteine-mediated cross-linking studies were performed. Unique cysteine residues were introduced over the surface of subunit H from yeast by site-directed mutagenesis and used as the site of attachment of the photo-activated cross-linking reagent maleimido benzophenone (MBP). Following UV-activated cross-linking, cross-linked products were identified by Western blot using subunit specific antibodies. The results indicate that the subunit H mutant S381C shows cross-linking between subunit H and subunit F (a rotor subunit) in the free V1 domain but not in the intact V1V0 complex. These results indicate that subunits H and F are proximal in free V1, supporting the hypothesis that subunit H inhibits free V1 by bridging the rotary and stator domains.
The pH within intracellular compartments is a critical and highly regulated parameter involved in an array of cellular processes, such as receptor-medicated endocytosis, intracellular membrane transport, prohormone processing, protein degradation and the coupled transport of small molecules (1). The primary regulator of pH within intracellular compartments is the vacuolar (H+) ATPase (V-ATPase1) (16). The V-ATPases are ATP-dependent proton pumps present in a variety of intracellular compartments including clathrin-coated vesicles, endosomes, Golgi-derived vesicles, lysosomes, secretory vesicles, and the central vacuoles of yeast, Neurospora, and plants. V-ATPases also localize to the plasma membrane of various specialized cells and facilitate processes such as bone resorption by osteoclasts (7), acid secretion by renal intercalated cells (3), pH homeostasis in macrophages and neutrophils (8) and sperm maturation and storage in the vas deferens and epididymis (9). Plasma membrane V-ATPases have also been implicated in the invasiveness of certain tumor cell lines (10).
The V-ATPase is a hetero-oligomeric complex composed of 14 different subunits arranged in two structural domains, V1 and V0 (16). ATP hydrolysis occurs in the peripheral V1 domain, a 640 kDa complex containing eight different subunits (A, B, C, D, E, F, G, H), whereas proton translocation occurs through the 250-kDa integral domain, V0, which is composed of six different subunits (a, d, e, c, c′, c″). These two domains are connected by both a central stalk, containing subunits D, F and d and peripheral stalks containing subunits C, E, G, H, and the hydrophilic N-terminal domain of subunit a (1114). The V-ATPase shares considerable structural similarity with the ATP synthase, for which a partial high-resolution crystal structure has been obtained (15).
Like the F-ATPase, the V-ATPase employs a rotary mechanism (16,17). The energy from ATP hydrolysis in the hexameric A3B3 head drives rotation of the central stalk and connected ring of proteolipid subunits (c, c′ and c″). Rotation of the proteolipid ring relative to subunit a of the V0 domain is thought to drive transport of protons across the membrane (1). Subunit a is held fixed relative to the hexameric head of V1 by the peripheral stalk, which functions as a stator in preventing unproductive rotation. Although sequence homology exists between the V and F-ATPases in both the nucleotide binding and the proteolipid subunits, there is virtually no sequence similarity for the remaining subunits.
An important mechanism of regulating V-ATPase activity in vivo involves dissociation into its component V1 and V0 domains, and the subsequent silencing of their respective functions (1,2). In yeast, dissociation occurs rapidly and reversibly in response to glucose withdrawal (18). This mechanism has been shown to regulate V-ATPase activity in cells of higher eukaryotes as well, including mammalian renal and dendritic cells and insect midgut cells (1921). Activation of antigen processing in dendritic cells causes assembly of the V-ATPase (20), which enhances proteolytic cleavage of antigen, while in renal cells the assembly status of the V-ATPase is also modulated by glucose (19). V-ATPase dissociation occurs in goblet cells of the insect midgut during molting as a means to preserve energy stores and is reversed following completion of the molting process (21). A general property of this mechanism is that upon dissociation of the two domains, the ATPase activity of the V1 domain and the passive proton conductance of the V0 domain are blocked (22,23). This is critical as rapid dissipation of intracellular proton gradients would occur if V0 passively conducted protons, and cellular energy stores would be significantly depleted upon the release of an uncoupled ATPase into the cytosol.
Subunit H of the V-ATPase in yeast has been shown to play an essential role in silencing ATP hydrolysis by V1. Thus, isolated V1 complexes depleted of subunit H show significant levels of ATPase activity compared to wild-type V1 complexes containing subunit H (22). The importance of suppressing the activity of the free V1 domain is highlighted by the observation that in mutant yeast strains in which all of the V1 domains are free in the cytosol, the absence of subunit H is lethal (24). In addition, yeast strains bearing half the normal amount of subunit H show a conditional lethal phenotype and possess free V1 domains displaying elevated Mg-ATPase activity (25). Cross-linking and EM studies performed on the V-ATPase from yeast and clathrin coated vesicles suggest that subunit H is localized to the peripheral stator near the interface between the V1 and V0 domains (13). Consistent with this localization of subunit H are co-immunoprecipitation and co-localization studies demonstrating interaction between subunit H and other peripheral stator subunits, including subunit E and the N-terminal domain of subunit a (2628). Based upon these observations, we hypothesize that subunit H inhibits ATP hydrolysis by the free V1 domain by bridging the peripheral and central stalks, serving as a mechanical brake to prevent ATP-driven rotation.
In this study we have employed cysteine-mediated cross-linking using the photo-activated cross-linking reagent maleimido benzophenone (MBP) (11) to probe the arrangement of subunits relative to subunit H in both free V1 and fully assembled V1V0. Unique cysteine residues were introduced over the surface of subunit H by site-directed mutagenesis using the available high-resolution structure of the yeast protein (29). These cysteine residues were then used as the site of attachment of MBP. The results indicate that subunit H and subunit F (one of the rotor subunits) are proximal in the free V1 domain but not in the intact V1V0, supporting the hypothesis that subunit H inhibits ATP hydrolysis in V1 by bridging the rotor and stator stalks.
Materials and Strains
Concanamycin A and 9-amino-6-chloro-2-methoxyacridine (ACMA), were purchased from Fluka Chemical Corp. and Invitrogen, respectively. Pre-cast polyacrylamide Ready-Gels, Tween 20, SDS, nitrocellulose membranes (0.45 μm pore size), and horseradish peroxidase-conjugated goat anti-rabbit and goat anti-mouse IgG were from BioRad. Zymolyase 100T was purchased from Seikagaku America, Inc. 4-(N-maleimido)benzophenone (MBP), and most common chemicals were purchased from Sigma. PEG-Maleimide (SunBio Co.) was a gift from Dr. Carol Deutsch. The chemiluminescence substrate for horseradish peroxidase was from KPL Laboratories. Kodak BioMax MR film was used for Western Blotting. Amicon Ultra concentration tubes (100K) were used for buffer exchange and concentration of the V1 sub-complex. PVDF syringe filters (0.45 μm) were purchased from Millipore.
The VMA13 gene in yeast encodes the H subunit. A yeast strain lacking subunit H was constructed from YPH500 by replacing the VMA13 gene with the TRP1 gene (vma13Δ::TRP1). The strain was first selected on plates lacking tryptophan and the growth phenotype was then assessed on YEPD plates buffered with 50 mM KH2PO4 and 50 mM succinic acid to either pH 7.5 or pH 5.5.
Antibodies
Monoclonal antibodies against subunits a, A, and B, were purchased from Molecular Probes. The polyclonal antibody against subunit E (Vma4p) was a gift from Dr. Daniel Klionsky (University of Michigan). The polyclonal antibodies against subunits H, D and F were a gift from Dr. Tom Stevens (University of Oregon).
Cloning of the VMA13 Gene encoding Subunit H
Genomic DNA was isolated from an adenine deficient yeast strain of YPH500 and used to amplify the VMA13 gene. The following primers with unique restriction enzymes sites for SacI and KpnI (underlined) were used: forward, 5′-GGCGAGCTCGTCGCCAGGGAAGGTTACGG -3′; reverse, 5′-GGCGGTACCGCGCCCATTAATACCCGACT-3′. The resulting PCR product was then digested with SacI and KpnI and ligated into pRS316.
Construction of Mutants
Mutations of Vma13p were performed using Promega’s Altered Sites II in vitro site-directed mutagenesis system. The VMA13 gene was cloned into the pALTER-1 vector using the SacI and KpnI restriction sites. To construct a cysteine-less (Cys-less) mutant of VMA13, the seven endogenous cysteine residues at postions 92, 183, 186, 290, 297, 298, and 369 were replaced with serine residues using the oligonucleotides listed in Table 1.
Table 1
Table 1
Sequences of oligonucleotides used to generate VMA13 mutantsa
Single cysteine residues were introduced into the Cys-less form of Vma13p also using Altered Sites II. The oligonucleotides for the single cysteine mutants constructed are listed in Table 1. After mutagenesis, each plasmid was digested with SacI and KpnI, and the resulting fragment was purified by agarose gel electrophoresis and ligated into pRS316. The final sequence of all mutants was confirmed by DNA sequencing.
Transformation and Selection
YPH500 yeast cells lacking functional endogenous Vma13p (vma13Δ::TRP1) were transformed by electroporation. The transformants were selected on uracil-minus plates, and the growth phenotypes were evaluated on yeast extract-peptone-dextrose plates buffered with KH2PO4 and 50 mM succinic acid to either pH 7.5 or pH 5.5.
Preparation of the V1 sub-complex
125 ml of yeast cells were grown overnight at 30°C to an absorbance (600nm) of ~1.7 in selective medium and washed twice with water. After resuspension in 5 mls of alkaline buffer (100 mM Tris-Cl, 10 mM DTT, pH 9.4), cells were incubated with gentle agitation at 30°C for 20 minutes. Cells were pelleted again, washed with YEPD medium (0.7 M sorbitol, 2 mM dithiothreitol, 100 mM MES-Tris, pH 7.5) and resuspended with 2.5 mls YEPD medium and 166 μg of Zymolyase. Cells were incubated for 1 hour at 30°C with gentle agitation. The resulting spheroplasts were washed with ice-cold 1.2 M sorbitol and resuspended in 2 mls osmotic lysis buffer (50 mM Tris-Cl, 200 mM Sorbitol, 1 mM EDTA, pH 7.5) and incubated on ice for 45 minutes. After incubation the spheroplasts were centrifuged at 100,000 × g to pellet all membranes, and the supernatant was collected and forced through a Millex-HV PVDF 0.45 μm syringe filter.
Isolation of Vacuolar Membrane Vesicles
Vacuolar membrane vesicles were isolated as described in our previous study (14). Briefly, 1 L of yeast cells were grown overnight at 30°C to an absorbance at 600nm of ~1.7 in selective medium, pelleted, washed twice with water, and re-suspended in 50 ml of alkaline buffer (described above). After incubation at 30°C for 20 minutes with gentle agitation, cells were pelleted again, washed once in 25 ml of YEPD medium and resuspended in the same YEPD medium including 2 mg of Zymolyase 100T. Cells were incubated for 1 hour at 30°C with gentle agitation. The resulting spheroplasts were osmotically lysed, and the vacuolar membranes were isolated by centrifugation on two consecutive Ficoll gradients (12% and 8%) and diluted in transport buffer (15 mM MES (4-morpholine ethanesulfonic acid)-Tris, 4.8% glycerol, pH 7).
Photochemical Cross-linking of the intact V1VO ATPase or V1 sub-complex with MBP
MBP-mediated cross-linking was performed on both the yeast cytosolic fraction, which contain the dissociated V1 sub-complex, and the vacuolar membranes, which contain the intact V1V0 complex. MBP dissolved in dimethylformamide was added to the purified vacuolar membranes or the V1 sub-complex containing fraction suspended in 100 μls to a final concentration of 1 mM, followed by incubation in the dark for 30 minutes at 23°C. Unreacted MBP was quenched by addition of 10 mM DTT. The vacuolar membranes were pelleted and washed twice with PBS-EDTA with protease inhibitors, resuspended in 100 μl of PBS-EDTA. The V1 containing fractions were washed twice with PBS-EDTA using a 100 K Amicon Ultra centrifugal filter, and spun to a final volume of 100 μl PBS-EDTA. Samples were then irradiated with a long wavelength (366 nm) ultraviolet lamp (Mineralight® model UVGL-25) at 4°C for 5 minutes.
Analysis of Cross-Linked Products
After cross-linking with MBP, vacuolar membranes were solubilized with 2% C12E9 and the intact V1V0 complexes were immunoprecipitated using an antibody against subunit A. The immunoprecipitated intact complexes or the cytosolic fraction containing the V1 complex were separated by SDS-PAGE on 7.5% acrylamide gels and then transferred to nitrocellulose. Western blotting using antibodies specific for subunit H or other V-ATPase subunits were used to detect MBP-dependent cross-linked products as previously described (11,14).
Sulfhydryl modification with PEG maleimide
To determine the accessibility of the sulfhydryl groups of various mutants, both isolated vacuoles and crude V1 preparations were incubated with 1 mM polyethylene glycol maleimide (PEG-Mal, 5 kDa) in PBS for 30 minutes at room temperature and quenched with 10 mM DTT. After quenching, the samples were mixed with sample buffer and separated by SDS-PAGE on 7.5% acrylamide gels. Samples were transferred to nitrocellulose and blotted with antibodies against subunit H. Although the PEG-maleimide has a molecular mass of 5 kDa, it causes a shift in apparent mobility of 10–15 kDa, depending upon the exact site of modification.
Other Procedures
Protein concentrations were determined by the Bradford and Lowry methods. ATPase activity was measure using a coupled spectrophotometric assay in the presence or absence of 1 μM concanamycin A as described previously (30). ATP-dependent proton transport was measured using the fluorescence probe ACMA in the presence or absence of 1 μM concanamycin A as described previously (30).
Construction of single cysteine-containing mutants of Vma13p and the effect of mutations on growth phenotype, ATPase activity, and proton transport activity
To determine the proximity of other V-ATPase subunits to specific sites within subunit H in both the V1 domain and the assembled V1V0 complex, we employed a cysteine mediated cross-linking strategy using the photoactivatable cross-linker, MBP ( 11). These studies allowed us to test the hypothesis that subunit H is able to interact with subunits of the central rotary stalk in V1 but not V1V0. The available crystal structure of subunit H (29) facilitated the introduction of single cysteine residues into structurally defined sites on the surface of subunit H.
Prior to the construction of single cysteine bearing mutants of subunit H, it was first necessary to prepare a construct of Vma13p (yeast subunit H) in which the endogenous cysteines were removed and replaced with serine residues. Serine residues were chosen as a substitute for cysteine because they most closely resemble cysteine in charge and size. The cys-less mutant of subunit H was constructed by replacing each of the seven endogenous cysteine residues (which occur at positions 92, 183, 186, 290, 297, 298, and 369) with serine residues using site-directed mutagenesis, as described under Experimental Procedures. Using the available high-resolution crystal structure of subunit H as a guide (29), single cysteine residues were then introduced by site-directed mutagenesis into 17 sites over the surface of the cys-less form of Vma13p (Fig. 1). All constructs were cloned into the pRS316 expression vector, which contains the URA3 selectable marker. Additionally, the wild-type VMA13 gene was cloned from YPH500 genomic DNA and inserted into pRS316 as well. All subsequent references to wild-type VMA13 refer to this construct in the vma13Δ yeast strain.
Figure 1
Figure 1
Location of unique cysteine residues introduced into the yeast V-ATPase subunit H (Vma13p)
All constructs were then transformed by electroporation into a vma13Δ strain of YPH500 yeast bearing the TRP1 marker (vma13Δ::TRP1) which had been prepared by homologous recombination. Wild-type VMA13 was included as a positive control for growth phenotype and activity assays (as described below), while the vma13Δ strain transformed with the pRS316 plasmid alone was used as a negative control.
All mutants were selected from uracil-minus plates and the growth phenotypes were assessed on YEPD plates buffered to either pH 7.5 or 5.5. The wild-type, cys-less and single cysteine mutants of Vma13p were all able to grow at both acid and neutral pH, indicating that each mutant can complement the vma- phenotype of the vma13Δ strain. Previous studies have shown that V-ATPase mutants that can grow at pH 7.5 have at least 20% of wild-type levels of V-ATPase activity (31,32).
Concanamycin-sensitive proton transport and ATPase activity were then determined for vacuolar membranes isolated from each yeast strain (Fig. 2). Vacuolar membranes from all mutants that gave identifiable cross-linked products (see below) possessed concanamycin-sensitive ATPase and proton pumping activities that were between 40 and 100% of wild-type activity, suggesting that all of these single cysteine mutants of subunit H are able to assemble into a V-ATPase complex possessing significant function. Interestingly, the T354C mutant had higher than wild-type levels of ATPase activity, but was not further pursued as no cross-linked products were observed for this mutant.
Figure 2
Figure 2
Effect of Vma13p mutations on ATPase and proton-pumping activity of the V-ATPase complex
Photochemical cross-linking of V-ATPase complexes containing mutant forms of Vma13p using MBP
The structural arrangement of V-ATPase subunits with respect to the single cysteine mutations of subunit H was determined using the photoreactive reagent maleimido benzophenone (MBP). This reagent possesses a linker arm of 10Å and forms a covalent bond with sulfhydryl groups via the maleimide moiety (11). Upon exposure to UV light, a reactive species is generated that is capable of covalently reacting with proximal residues, thus forming a cross-link between the sulfhydryl-bearing subunit H and proteins within 10Å.
Because many of the other V-ATPase subunits possess endogenous cysteine residues, even in complexes containing a cys-less form of subunit H, it is critical to determine whether MBP could react with these sulfhydryl groups and cross-link to subunit H upon UV exposure. To test this, both vacuolar membranes and cytosolic V1 complexes were isolated from the yeast strain expressing the cys-less form of Vma13p and reacted with 1 mM MBP for 30 minutes in the dark followed by quenching of the reagent with 10 mM DTT. After washing to remove unreacted reagent and irradiation with a long-wavelength UV lamp, the products were separated by SDS-PAGE and analyzed by Western blot using antibodies against subunit H. As shown in Figures 3a and and4a,4a, no reactive bands of molecular weight greater than that of subunit H (54 kDa) appear in the presence of MBP. This demonstrates that any cross-linked products involving the single cysteine mutants of subunit H are not a result of MBP reacting with the sulfhydryl groups of other subunits.
Figure 3
Figure 3
Subunit H mutant cross-links in free V1 complexes using MBP
Figure 4
Figure 4
Subunit H mutant cross-links in intact V1VO complexes using MBP
To identify subunits within close proximity to subunit H in free V1 complexes, the cytosol from each mutant strain and wild-type was collected, concentrated, incubated with MBP, quenched with DTT, exposed to UV light and analyzed by Western blot. Of the 18 strains tested (which includes 17 cysteine mutants and the cysteine-less mutant as a negative control), five produced MBP-dependent products that react with an antibody directed against subunit H. These include mutants P197C, Q265C, T300C, S381C, and D390C. Of these mutants, only S381C and D390C gave cross-lined products that could be conclusively identified with antibodies against other subunits. In each case the cross-linked product had an apparent molecular weight larger than subunit H. Mutant D390C produced an MBP dependent product recognized by the anti-H subunit of molecular mass about 114 kDa (Fig. 3b). As this is approximately equal to the sum of the molecular masses of subunit H (Mr 54 kDa) and subunit B (Mr 60 kDa), Western blotting was performed with this mutant using an antibody specific for subunit B. As shown in the Figure 3b, the 114 kDa cross-linked band is also recognized by the anti-B subunit antibody, suggesting the formation of an H/B hetero-dimer in this mutant in free V1. Mutant S381C showed an MBP dependent product of molecular mass about 70 kDa. Subunits F or G (Mr 14 and 10 kDa) are the only V1 domain subunits that could cross-link to subunit H and produce a product of this mass. As shown in Figure 3c, Western blotting using an antibody specific for subunit F revealed the 70 kDa cross-linked product to be an H/F heterodimer, suggesting that S381 of subunit H is in close proximity to subunit F in the free V1 domain. Mutant P197C produced a MBP dependent product of about 105 kDa (Fig. 3d) which was not identifiable using antibodies directed against other V-ATPase subunits, including subunits E, D and B (data not shown). No structural conclusions can be drawn from the mutants that did not yield cross-linked products as it is possible that the cysteine residues in these mutants were not accessible to MBP, or, if accessible, did not yield photoreactive species oriented correctly for cross-linking to occur.
MBP-dependent cross-linking was next analyzed for all 17 single cysteine-containing mutants of subunit H in intact V1V0 complexes. Vacuolar membranes bearing fully assembled V-ATPase complexes were isolated from each mutant strain and wild-type, reacted with MBP, exposed to UV light and analyzed. Four cysteine mutants (S42C, P197C, Q265C, and T300C) repeatedly showed MBP-dependent bands of molecular mass greater than subunit H, although only the product formed from P197C could be identified with antibodies against another subunit. Mutant D390C did not show any cross-linked products in V1V0 (data not shown). Mutant P197C produced an MBP-dependent band at about 105 kDa that reacts with both anti-H and anti-E subunit antibodies (Fig. 4b). Although the molecular mass of this cross-linked product is greater than that expected of an H/E heterodimer (81 kDa), it is likely that, due to cross-linking near the middle of either subunit, this species migrates aberrantly on SDS-PAGE. We have previously observed that cross-linked products between the same two subunits migrated differently depending upon where within the primary sequences the cross-linking occurred (11,12). These results suggest that subunits H and E are in close proximity in the fully assembled complex near the middle of subunit H.
Interestingly, mutant P197C also shows an MBP dependent product of molecular mass about 105 kDa when cross-linking is performed in free V1, as noted above. Although this product did not react with antibodies against subunit E, it is possible that the site within subunit E that undergoes cross-linking is different in free V1 and intact V1V0, and that as a result the epitope recognized by the anti-E subunit antibody becomes masked in V1. Although the antisera against subunit E is polyclonal and it is unlikely that all of the epitopes become masked by a single cross-linking event, cross-linking may have masked the primary epitope in subunit E. It is also possible that the cross-link involves a subunit not tested for (such as A or C) or involves a novel protein.
Significantly, mutant S381C, which resulted in H-F cross-linking in the free V1 domain, did not show cross-linking in V1V0 (Fig. 4a). One explanation of this negative result is that the S381C residue is inaccessible to sulfhydryl modifying reagents in the intact V-ATPase complex. To test this possibility, both V1 and vacuolar membrane preparations containing V1V0 from the S381C mutant and four other mutants were reacted with the sulfhydryl reagent PEG- maleimide followed by SDS-PAGE and blotted with the anti-H antibody. Because reaction with PEG-maleimide shifts the mobility of the protein by 10–15 kDa, this experiment identifies mutants possessing cysteine residues that are solvent exposed (33). As can be seen in Figure 5, the S381C mutant shows reactivity with PEG-maleimide in both free V1 and the intact V1VO complex that is comparable to that observed for the other cysteine residues tested. These results suggest that the absence of an S381C cross-link in the intact complex is not due to the inaccessibility of the cysteine residue at this position. It should be noted that the variable mobility of the PEG-maleimide-modified cysteine mutants, depending upon the location of the cysteine residue within the primary sequence, is consistent with the proposed explanation for the aberrant mobility of some of the observed cross-linked products noted above.
Figure 5
Figure 5
Reactivity of the cysteine mutants of Vma13p to PEG-maleimide in free V1 and V1V0 complexes
Eukaryotic cells are able to modulate the pH of their intracellular compartments independently and in response to a variety of stimuli. In yeast, removal of glucose from the media causes reversible dissociation of V1V0 complexes, thus preserving cellular ATP stores (18). Because reversible dissociation is widely used as a mechanism of regulating V-ATPase activity in vivo, it is important that the ATPase activity of free V1 and the passive proton conductance of free V0 be suppressed as a means to avoid physiologically catastrophic consequences.
Based upon the inhibitory effect of subunit H on the ATPase activity of the free V1 domain and on its localization to the peripheral stator, we hypothesize that subunit H inhibits catalysis by bridging the rotor and stator domains and thus physically blocking rotation. The results presented in this study suggest that subunit H comes within 10 Å of subunit F (a rotor subunit) in the free V1 domain but not in the intact V-ATPase complex, and are thus consistent with the proposed mechanism by which subunit H inhibits rotary catalysis. Moreover, they identify the C-terminal domain of subunit H as the critical region for inhibition of activity.
The crystal structure of subunit H reveals that it is an elongated protein consisting of an N-terminal domain (residues 2–352) and a C-terminal domain (residues 353–478) which are separated by a four residue loop suggesting structural flexibility between the two domains (29). The N-terminal domain, composed largely of stacked α-helices, contains a hydrophobic groove, similar to that observed in importins, which may function as a protein-protein binding domain. In fact, subunit H has been shown to function as the binding site for a number of other proteins that associate with the V-ATPase, including the HIV-NEF protein, the AP-2 adaptor complex and the Golgi ectoapyrase (34,35). Interestingly, the N-terminal domain of subunit H has been shown to partially support an uncoupled ATPase activity by the V-ATPase complex, but requires the C-terminal domain to recover coupling of proton transport and ATPase activity (36).
Subunit F is a 14-kDa protein which has been shown, along with subunit D, to form part of the rotor by direct rotational studies performed on the V-ATPase from T. thermophilus (16). Therefore any direct interaction between subunit H and subunit F would be expected to prevent rotary catalysis. It should be noted, however, that these results do not rule out other possible mechanisms by which subunit H may inhibit activity. The inhibitory protein of the mitochondrial ATP synthase, for example, has been shown to inhibit ATP hydrolysis by intercalating into an interface of the alpha and beta subunits and preventing a critical conformational change from occurring that is required for catalysis (37). It is possible that subunit H may inhibit ATP hydrolysis in V1 by a similar mechanism. Nevertheless, the results do point toward a reversible interaction of the C-terminal domain of subunit H and the rotor stalk upon dissociation of the V1 and V0 domains and are thus supportive of a bridging mechanism.
Significantly, the lack of cross-linking between subunits H and F in the assembled complex is not due to an inaccessibility of the cysteine residue at position 381 to the cross-linking reagent, since this residue is still capable of reacting with PEG-maleimide in the intact complex. Rather, this result suggests that a conformational change moves the C-terminal domain of subunit H towards the rotor stalk upon dissociation of V1 and V0.
The recent high-resolution crystal structure of subunit F from T. thermophilus reveals that the N and C-terminal domains are connected by a flexible loop, allowing the protein to adopt either a “retracted” or an “extended” conformation, both of which were detected by FRET analysis (38). This is similar to the situation observed for the F-ATPase ε subunit, which also forms part of the rotary stalk in the ATP synthase (39), although the two proteins are not otherwise structurally related. It is possible that either a change in conformation of subunit F, or a movement of the C-terminal domain of subunit H, or both, allows these two proteins to become proximal upon dissociation of V1. Interestingly, because it is the retracted form of subunit F that is observed in the absence of ATP, it is predicted that it would be this form of the protein that would interact with subunit H upon dissociation of V1. Although the assembly status of the V-ATPase in vivo has been shown not to directly track the ATP levels in the cell (40), it is nevertheless possible that a transient drop in ATP concentration upon removal of glucose may activate the dissociation process.
Additionally, the results of this study indicate that subunit H interacts with the B subunit in the dissociated V1 domain, and with subunit E in the intact V-ATPase complex. Although we could not detect an H-B subunit interaction in the intact complex, previous studies have shown that the C-terminal domain of subunit B interacts with subunit H in V1VO (13). Our results refine this picture by showing that it is the C-terminal domain of subunit H that participates in this interaction in the V1 domain. Since the sites of cross-linking to subunit F and subunit B in V1 are in quite close proximity to each other on the surface of subunit H, it is possible that it is only the C-terminal domain of H that is required to bridge the rotor and stator. By contrast, the N-terminal domain of subunit H interacts with subunit E, which in turn interacts with subunit H via a region in its N-terminus (27). Subunit E is a 26 kDa protein present in multiple copies per complex (41) that appears to stretch a considerable distance perpendicular to the membrane (11,12) and has been shown to interact with many of the peripheral stalk subunits including subunits B, C and G (11,14,41,42).
In summary, we have demonstrated that the N-terminal domain of subunit H is in proximity to subunit E in the intact V1VO complex, while the C-terminal domain is in proximity to subunit B in the free V1 domain. Moreover, the C-terminal domain of subunit H becomes proximal to the rotary subunit F only in the free V1 domain, consistent with the proposed mechanism of inhibition by subunit H of catalysis by the V1 domain via bridging of the rotor and stator portions of the complex.
Acknowledgments
We thank Drs. Takao Inoue, Ayana Hinton, Dan Cipriano, and Yanru Wang, as well as Jie Qi and Sarah Bond for their helpful discussions. We also wish to thank Drs. Tom Stevens and Daniel Klionsky for generously providing us anti-Vma13p and anti-Vma4p antibodies. Additionally, we would like to thank Dr. Carol Deutsch for providing us PEG-maleimide.
This work was supported by National Institutes of Health Grant GM 34478 (to M.F.). E.coli strains were provided through NIH Grant DK34928.
Footnotes
1The abbreviations used are: V-ATPase, vacuolar proton-translocating adenosine 5′-triphosphatase; F-ATPase, F1F0 ATP synthase; MBP, 4-(N-maleimido)benzophenone; PEG-maleimide, polyethylene glycol maleimide; PAGE, polyacrylamide gel electrophoresis; ACMA, 9-amino-6-chloro-2-methoxyacridine C12E9, polyoxyethylene 9-lauryl ether; YEPD, yeast extract-peptone-dextrose; DTT, dithiothreitol; PBS, phosphate buffered saline
1. Forgac M. Nat Rev Mol Cell Biol. 2007;8(11):917–929. [PubMed]
2. Kane PM. Microbiol Mol Biol Rev. 2006;70(1):177–191. [PMC free article] [PubMed]
3. Wagner CA, Finberg KE, Breton S, Marshansky V, Brown D, Geibel JP. Physiol Rev. 2004;84(4):1263–1314. [PubMed]
4. Nelson N. J Bioenerg Biomembr. 2003;35(4):281–289. [PubMed]
5. Sun-Wada GH, Wada Y, Futai M. Biochim Biophys Acta. 2004;1658(1–2):106–114. [PubMed]
6. Inoue T, Wang Y, Jefferies K, Qi J, Hinton A, Forgac M. J Bioenerg Biomembr. 2005;37(6):393–398. [PubMed]
7. Toyomura T, Murata Y, Yamamoto A, Oka T, Sun-Wada GH, Wada Y, Futai M. J Biol Chem. 2003;278(24):22023–22030. [PubMed]
8. Nanda A, Brumell JH, Nordstrom T, Kjeldsen L, Sengelov H, Borregaard N, Rotstein OD, Grinstein S. J Biol Chem. 1996;271(27):15963–15970. [PubMed]
9. Pietrement C, Sun-Wada GH, Silva ND, McKee M, Marshansky V, Brown D, Futai M, Breton S. Biol Reprod. 2006;74(1):185–194. [PubMed]
10. Sennoune SR, Bakunts K, Martinez GM, Chua-Tuan JL, Kebir Y, Attaya MN, Martinez-Zaguilan R. Am J Physiol, Cell Physiol. 2004;286(6):C1443–1452. [PubMed]
11. Arata Y, Baleja JD, Forgac M. Biochemistry. 2002;41(37):11301–11307. [PubMed]
12. Arata Y, Baleja JD, Forgac M. J Biol Chem. 2002;277(5):3357–3363. [PubMed]
13. Wilkens S, Inoue T, Forgac M. J Biol Chem. 2004;279(40):41942–41949. [PubMed]
14. Inoue T, Forgac M. J Biol Chem. 2005;280(30):27896–27903. [PubMed]
15. Stock D, Leslie AG, Walker JE. Science. 1999;286(5445):1700–1705. [PubMed]
16. Imamura H, Nakano M, Noji H, Muneyuki E, Ohkuma S, Yoshida M, Yokoyama K. Proc Natl Acad Sci U S A. 2003;100(5):2312–2315. [PubMed]
17. Hirata T, Iwamoto-Kihara A, Sun-Wada GH, Okajima T, Wada Y, Futai M. J Biol Chem. 2003;278(26):23714–23719. [PubMed]
18. Kane PM. J Biol Chem. 1995;270(28):17025–17032. [PubMed]
19. Sautin YY, Lu M, Gaugler A, Zhang L, Gluck SL. Mol Cell Biol. 2005;25(2):575–589. [PMC free article] [PubMed]
20. Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I. Science. 2003;299(5611):1400–1403. [PubMed]
21. Beyenbach KW, Wieczorek H. J Exp Biol. 2006;209(Pt 4):577–589. [PubMed]
22. Parra KJ, Keenan KL, Kane PM. J Biol Chem. 2000;275(28):21761–21767. [PubMed]
23. Zhang J, Myers M, Forgac M. J Biol Chem. 1992;267(14):9773–9778. [PubMed]
24. Keenan Curtis K, Kane PM. J Biol Chem. 2002;277(4):2716–2724. [PubMed]
25. Rizzo JM, Tarsio M, Martinez-Munoz GA, Kane PM. J Biol Chem. 2007;282(11):8521–8532. [PubMed]
26. Landolt-Marticorena C, Williams KM, Correa J, Chen W, Manolson MF. J Biol Chem. 2000;275(20):15449–15457. [PubMed]
27. Lu M, Vergara S, Zhang L, Holliday LS, Aris J, Gluck SL. J Biol Chem. 2002;277(41):38409–38415. [PubMed]
28. Fethiere J, Venzke D, Madden DR, Bottcher B. Biochemistry. 2005;44(48):15906–15914. [PubMed]
29. Sagermann M, Stevens TH, Matthews BW. Proc Natl Acad Sci U S A. 2001;98(13):7134–7139. [PubMed]
30. Vasilyeva E, Liu Q, MacLeod KJ, Baleja JD, Forgac M. J Biol Chem. 2000;275(1):255–260. [PubMed]
31. Liu J, Kane PM. Biochemistry. 1996;35(33):10938–10948. [PubMed]
32. MacLeod KJ, Vasilyeva E, Baleja JD, Forgac M. J Biol Chem. 1998;273(1):150–156. [PubMed]
33. Lu J, Deutsch C. Biochemistry. 2001;40(44):13288–13301. [PubMed]
34. Geyer M, Yu H, Mandic R, Linnemann T, Zheng YH, Fackler OT, Peterlin BM. J Biol Chem. 2002;277(32):28521–28529. [PubMed]
35. Zhong X, Malhotra R, Guidotti G. J Biol Chem. 2000;275(45):35592–35599. [PubMed]
36. Liu M, Tarsio M, Charsky CM, Kane PM. J Biol Chem. 2005;280(44):36978–36985. [PMC free article] [PubMed]
37. Cabezon E, Montgomery MG, Leslie AG, Walker JE. Nat Struct Biol. 2003;10(9):744–750. [PubMed]
38. Makyio H, Iino R, Ikeda C, Imamura H, Tamakoshi M, Iwata M, Stock D, Bernal RA, Carpenter EP, Yoshida M, Yokoyama K, Iwata S. EMBO J. 2005;24(22):3974–3983. [PubMed]
39. Kato-Yamada Y, Noji H, Yasuda R, Kinosita K, Jr, Yoshida M. J Biol Chem. 1998;273(31):19375–19377. [PubMed]
40. Parra KJ, Kane PM. Mol Cell Biol. 1998;18(12):7064–7074. [PMC free article] [PubMed]
41. Ohira M, Smardon AM, Charsky CM, Liu J, Tarsio M, Kane PM. J Biol Chem. 2006;281(32):22752–22760. [PubMed]
42. Jones RP, Durose LJ, Findlay JB, Harrison MA. Biochemistry. 2005;44(10):3933–3941. [PubMed]